Drug Metabolism Reviews

Papers
(The median citation count of Drug Metabolism Reviews is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The annoying flaws of gerontological research42
Drug transporters in drug disposition – the year 2022 in review36
Cell-Biomaterial constructs for wound healing and skin regeneration33
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids29
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models26
Mechanisms of intestinal pharmacokinetic natural product-drug interactions23
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments19
Bioanalytical strategies in drug discovery and development19
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations17
Rodent genetic models of Ah receptor signaling15
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism15
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population13
Biopolymers as promising vehicles for drug delivery to the brain13
Clinical pharmacokinetics of nebivolol: a systematic review12
Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature12
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism11
Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice11
Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations 11
Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods10
In silico ADME and target prediction studies of Alogliptin as drug molecule10
Recent advances in drug transporter sciences: highlights from the year 202010
Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-1910
Toxicity mechanisms of nanoparticles in the male reproductive system9
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs8
Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy8
In-depth understanding of the structure-based reactive metabolite formation of organic functional groups7
The relationship between UGT1A1 gene & various diseases and prevention strategies6
Advances in drug resistance of osteosarcoma caused by pregnane X receptor6
Drug metabolic stability in early drug discovery to develop potential lead compounds5
Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development5
Regulation of human UDP-glycosyltransferase (UGT) genes by miRNAs4
Biotransformation research advances – 2023 year in review4
Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery4
Cutting-edge strategies and critical advancements in characterization and quantification of metabolites concerning translational metabolomics4
Physiological and pathophysiological roles of hepoxilins and their analogs4
Interaction of drugs with gut microbiota modulators4
Relationship between blood–brain barrier changes and drug metabolism under high-altitude hypoxia: obstacle or opportunity for drug transport?4
Metabolism of m -CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects4
3D self-assembled nanocarriers for drug delivery4
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms3
The role and current research status of resveratrol in the treatment of osteoarthritis and its mechanisms: a narrative review3
Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy3
Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic3
Ocular drug-metabolizing enzymes: focus on esterases3
Drug transporters in drug disposition – highlights from the year 20233
The aminosalicylate - folate connection3
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy3
The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure3
Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review3
0.030858993530273